Viscous Fiber Supplements for Diabetes Control
Diabetes Care

Summary
This systematic review and meta-analysis evaluated the effect of viscous fiber supplementation on glycemic control in individuals with type 2 diabetes. A total of 28 randomized controlled trials (RCTs) with 1,394 participants were analyzed. The findings indicate that viscous fiber significantly reduces HbA1c, fasting blood glucose, and insulin resistance markers. The median dose of fiber supplementation was 13.1 g/day over a median duration of 8 weeks. The study concludes that viscous fiber can improve glycemic control and should be considered as part of diabetes management strategies. The study found that individuals with higher baseline HbA1c levels showed greater reductions in their glycemic markers. However, substantial heterogeneity among trials was observed. The certainty of the evidence was graded moderate for key glycemic markers and low for fructosamine. The authors suggest that dietary guidelines should be revised to promote viscous fiber intake for individuals with type 2 diabetes.
Study Design
Interventions
Study Type
Outcomes
Duration and Size
Study Population
Age Range
Sex
Geography
Other Criteria
Methodology
A systematic search was conducted across MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials for RCTs assessing the impact of viscous fiber on glycemic markers in type 2 diabetes. Studies with a minimum duration of 3 weeks were included. Data were extracted independently by two reviewers, and pooled results were analyzed using the generic inverse variance method. The certainty of evidence was graded using the GRADE system.
Interventions
Participants received a median dose of 13.1 g/day of viscous fiber supplementation, including psyllium, guar gum, konjac, and β-glucan. The interventions were provided in different forms, such as powder, capsules, and enriched foods. The study compared these interventions with fiber-free or insoluble fiber supplements.
Key Findings
Viscous fiber supplementation significantly reduced HbA1c (-0.58%), fasting blood glucose (-0.82 mmol/L), and insulin resistance (HOMA-IR reduction of 1.89). The findings support the inclusion of viscous fiber in diabetes management, particularly for individuals with elevated HbA1c levels.
Comparison with other Studies
This study confirms previous findings that dietary fiber can aid glycemic control. Compared to prior research grouping soluble and insoluble fiber, this study isolates the effects of viscous fiber, demonstrating its unique benefits. While insoluble fiber supports colonic health, viscous fiber has metabolic benefits, including improved glucose and lipid regulation.
Journal Reference
Jovanovski E, Khayyat R, Zurbau A, et al. Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2019;42(5):755-766. doi:10.2337/dc18-1126.
Related and Discussions
Dietary Fibre and Whole Grains in Diabetes Management: Systematic Review and Meta-Analyses
Stopping or reducing dietary fiber intake reduces constipation and its associated symptoms
Stopping or reducing dietary fiber intake reduces constipation and its associated symptoms
Effect of viscous fiber supplementation on obesity indicators in individuals consuming calorie-restricted diets: a systematic review and meta-analysis of randomized controlled trials
Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials
Understanding the Physics of Functional Fibers in the Gastrointestinal Tract: An Evidence-Based Approach to Resolving Enduring Misconceptions about Insoluble and Soluble Fiber
Systematic review with meta-analysis: effect of fibre supplementation on chronic idiopathic constipation in adults
Efficacy and Safety of Over-the-Counter Therapies for Chronic Constipation: An Updated Systematic Review
Stay informed. Stay ahead.
Subscribe now for the latest breakthroughs, expert insights, and cutting-edge updates in diabetes care—delivered straight to your inbox.